Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 138Terminated 47Withdrawn 16Recruiting 14Active not recruiting 8Unknown 4Not yet recruiting 4

Sponsor Class

NIH 11OTHER 4INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 4Dermatologic 2

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

romidepsin 1Standard of Care 1Lenalidomide 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Sezary Syndrome × Clear all
NCT02232516 2024-04-10

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Northwestern University

Phase 2 Unknown
30 enrolled 17 charts
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT03646422 2022-03-31

AEDV Registry of Primary Cutaneous Lymphoma

Fundación Academia Española de Dermatología

Unknown
2,000 enrolled
DermatologicLymphoid

Sezary Syndrome, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

NCT05206045 2022-01-25

SURPASSe

Assistance Publique - Hôpitaux de Paris

Unknown
700 enrolled
Lymphoid

Sezary Syndrome

NCT00157274 2007-04-03

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Latin American Cooperative Onco-Haematology Group - Peru

Phase 2 Unknown
20 enrolled
Lymphoid

Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡